THE USE OF BOTULINUM TOXIN INJECTION IN THE MANAGEMENT OF MYOFASCIAL PAIN DYSFUNCTION SYNDROME | ||||
Egyptian Dental Journal | ||||
Article 6, Volume 63, Issue 4 - October (Oral Surgery), October 2017, Page 3069-3075 PDF (1.02 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/edj.2017.76102 | ||||
View on SCiNiTO | ||||
Authors | ||||
Nashwa osama1; Sayed Attia2; Mohamed Farmawy3; Amany Hussien Nemmat4; Mahmoud Shalash4 | ||||
1Oral Surgery and Medicine Department, National Research Centre, Egypt | ||||
2Professor of Oral & Maxillofacial Surgery, Cairo University | ||||
3Lecturer of oral & Maxillofacial Surgery, Cairo University | ||||
4Oral Surgery and Medicine Department, National Research Centre, Egypt. | ||||
Abstract | ||||
Objectives: To evaluate the short-term effect of the botulinum toxin, type A (BTX-A) injection for the treatment of myofascial pain dysfunction syndrome. Materials & Methods: Foueteen female patients suffering from myofascial pain dysfunction syndrome were included in this study. For all patients both the masseter and temporalis muscles were injected once with 20-30 Units of BTX-A respectively and followed up for three months. Follow up included clinical assessment of maximal inter-incisal opening, range of lateral movement and visual analogue scale for pain. Electromyography (EMG) images were ordered pre-operatively and at the end of 3 months’ period to quantify the changes in muscle activity. Results: Results of the present study showed resolution of pain in all patients upon completing the follow up period. Conclusion: Within the limits of this study BTX-A can be used effectively for the treatment of myofacial pain dysfunction syndrome. | ||||
Statistics Article View: 130 PDF Download: 257 |
||||